The RNA-Mediated Disease Process in Myotonic Dystrophy

Genetic Instabilities and Neurological Diseases

Volumn , Issue , 2006, Pages 37-54

  Thornton, Charles A ^a   Swanson, Maurice S ^b   Cooper, Thomas A ^c  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^b UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^c BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 34250892914     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-012369462-1/50004-1     Document Type: Chapter

References (118)

1. Harley H.G., Brook J.D., Rundle S.A., Crow S., Reardon W., Buckler A.J., Harper P.S., Housman D.E., Shaw D.J. Expansion of an unstable DNA region and phenotypic variation in myotonic dystrophy. Nature 1992, 355:545-546.
2. Buxton J., Shelbourne P., Davies J., Jones C., Van Tongeren T., Aslanidis C., de Jong P., Jansen G., Anvret M., Riley B., et al. Detection of an unstable fragment of DNA specific to individuals with myotonic dystrophy. Nature 1992, 355:547-548.
3. Mahadevan M., Tsilfidis C., Sabourin L., Shutler G., Amemiya C., Jansen G., Neville C., Narang M., Barcelo J., O'Hoy K., et al. Myotonic dystrophy mutation: An unstable CTG repeat in the 3? untranslated region of the gene. Science 1992, 255:1253-1255.
4. Fu Y.H., Pizzuti A., Fenwick R.G., King J., Rajnarayan S., Dunne P.W., Dubel J., Nasser G.A., Ashizawa T., de Jong P., et al. An unstable triplet repeat in a gene related to myotonic muscular dystrophy. Science 1992, 255:1256-1258.
5. Brook J.D., McCurrach M.E., Harley H.G., Buckler A.J., Church D., Aburatani H., Hunter K., Stanton V.P., Thirion J.P., Hudson T., et al. Molecular basis of myotonic dystrophy: Expansion of a trinucleotide (CTG) repeat at the 3? end of a transcript encoding a protein kinase family member. Cell 1992, 69:385.
6. Wilkie A.O. The molecular basis of genetic dominance. J. Med. Genet. 1994, 31:89-98.
7. Taneja K.L., McCurrach M., Schalling M., Housman D., Singer R.H. Foci of trinucleotide repeat transcripts in nuclei of myotonic dystrophy cells and tissues. J. Cell. Biol. 1995, 128:995-1002.
8. Maeda M., Taft C.S., Bush E.W., Holder E., Bailey W.M., Neville H., Perryman M.B., Bies R.D. Identification, tissue-specific expression, and subcellular localization of the 80-and 71-kDa forms of myotonic dystrophy kinase protein. J. Biol. Chem. 1995, 270:20246-20249.
9. Furling D., Lemieux D., Taneja K., Puymirat J. Decreased levels of myotonic dystrophy protein kinase (DMPK) and delayed differentiation in human myotonic dystrophy myoblasts. Neuromuscul. Disord. 2001, 11:728-735.
10. Jansen G., Groenen P.J., Bachner D., Jap P.H., Coerwinkel M., Oerlemans F., van den Broek W., Gohlsch B., Pette D., Plomp J.J., et al. Abnormal myotonic dystrophy protein kinase levels produce only mild myopathy in mice. Nat. Genet. 1996, 13:316-324.
11. Reddy S., Smith D.B., Rich M.M., Leferovich J.M., Reilly P., Davis B.M., Tran K., Rayburn H., Bronson R., Cros D., et al. Mice lacking the myotonic dystrophy protein kinase develop a late onset progressive myopathy. Nat. Genet. 1996, 13:325-335.
12. Berul C.I., Maguire C.T., Aronovitz M.J., Greenwood J., Miller C., Gehrmann J., Housman D., Mendelsohn M.E., Reddy S. DMPK dosage alterations result in atrioventricular conduction abnormalities in a mouse myotonic dystrophy model. J. Clin. Invest. 1999, 103:R1-R7.
13. Berul C.I., Maguire C.T., Gehrmann J., Reddy S. Progressive atrioventricular conduction block in a mouse myotonic dystrophy model. J. Intervent. Card. Electrophysiol. 2000, 4:351-358.
14. Nguyen H.H., Wolfe J.T., Holmes D.R., Edwards W.D. Pathology of the cardiac conduction system in myotonic dystrophy: A study of 12 cases. J. Am. Coll. Cardiol. 1988, 11:662-671.
15. O'Cochlain D.F., Perez-Terzic C., Reyes S., Kane G.C., Behfar A., Hodgson D.M., Strommen J.A., Liu X.K., van den Broek W., Wansink D.G., et al. Transgenic overexpression of human DMPK accumulates into hypertrophic cardiomyopathy, myotonic myopathy and hypotension traits of myotonic dystrophy. Hum. Mol. Genet. 2004, 13:2505-2518.
16. Krahe R., Ashizawa T., Abbruzzese C., Roeder E., Carango P., Giacanelli M., Funanage V.L., Siciliano M.J. Effect of myotonic dystrophy trinucleotide repeat expansion on DMPK transcription and processing. Genomics 1995, 28:1-14.
17. Tiscornia G., Mahadevan M.S. Myotonic dystrophy: The role of the CUG triplet repeats in splicing of a novel DMPK exon and altered cytoplasmic DMPK mRNA isoform ratios. Mol. Cell. 2000, 5:959-967.
18. Otten A.D., Tapscott S.J. Triplet repeat expansion in myotonic dystrophy alters the adjacent chromatin structure. Proc. Natl. Acad. Sci. USA 1995, 92:5465-5469.
19. Klesert T.R., Otten A.D., Bird T.D., Tapscott S.J. Trinucleotide repeat expansion at the myotonic dystrophy locus reduces expression of DMAHP. Nat. Genet. 1997, 16:402-406.
20. Thornton C.A., Wymer J.P., Simmons Z., McClain C., Moxley R.T. Expansion of the myotonic dystrophy CTG repeat reduces expression of the flanking DMAHP gene. Nat. Genet. 1997, 16:407-409.
21. Alwazzan M., Newman E., Hamshere M.G., Brook J.D. Myotonic dystrophy is associated with a reduced level of RNA from the DMWD allele adjacent to the expanded repeat. Hum. Mol. Genet. 1999, 8:1491-1497.
22. Erksson M., Ansved T., Edstrom L., Anvret M., Carey N. Simultaneous analysis of expression of the three myotonic dystrophy locus genes in adult skeletal muscle samples: The CTG expansion correlates inversely with DMPK and 59 expression levels, but not DMAHP levels. Hum. Mol. Genet. 1999, 8:1053-1060.
23. Klesert T.R., Cho D.H., Clark J.I., Maylie J., Adelman J., Snider L., Yuen E.C., Soriano P., Tapscott S.J. Mice deficient in Six5 develop cataracts: Implications for myotonic dystrophy. Nat. Genet. 2000, 25:105-109.
24. Sarkar P.S., Appukuttan B., Han J., Ito Y., Ai C., Tsai W., Chai Y., Stout J.T., Reddy S. Heterozygous loss of Six5 in mice is sufficient to cause ocular cataracts. Nat. Genet. 2000, 25:110-114.
25. Philips A.V., Timchenko L.T., Cooper T.A. Disruption of splicing regulated by a CUG-binding protein in myotonic dystrophy. Science 1998, 280:737-741.
26. Miller J.W., Urbinati C.R., Teng-Umnuay P., Stenberg M.G., Byrne B.J., Thornton C.A., Swanson M.S. Recruitment of human muscleblind proteins to (CUG) (n) expansions associated with myotonic dystrophy. EMBO J. 2000, 19:4439-4448.
27. Zamore P.D., Haley B. Ribo-gnome: The big world of small RNAs. Science 2005, 309:1519-1524.
28. Mandal M., Boese B., Barrick J.E., Winkler W.C., Breaker R.R. Riboswitches control fundamental biochemical pathways in Bacillus subtilis and other bacteria. Cell 2003, 113:577-586.
29. Wang J., Pegoraro E., Menegazzo E., Gennarelli M., Hoop R.C., Angelini C., Hoffman E.P. Myotonic dystrophy: Evidence for a possible dominant-negative RNA mutation. Hum. Mol. Genet. 1995, 4:599-606.
30. Amack J.D., Paguio A.P., Mahadevan M.S. Cis and trans effects of the myotonic dystrophy (DM) mutation in a cell culture model. Hum. Mol. Genet. 1999, 8:1975-1984.
31. Mankodi A., Logigian E., Callahan L., McClain C., White R., Henderson D., Krym M., Thornton C.A. Myotonic dystrophy in transgenic mice expressing an expanded CUG repeat. Science 2000, 289:1769-1773.
32. Liquori C.L., Ricker K., Moseley M.L., Jacobsen J.F., Kress W., Naylor S.L., Day J.W., Ranum L.P. Myotonic dystrophy type 2 caused by a CCTG expansion in intron 1 of ZNF9. Science 2001, 293:864-867.
33. Kanadia R.N., Johnstone K.A., Mankodi A., Lungu C., Thornton C.A., Esson D., Timmers A.M., Hauswirth W.W., Swanson M.S. A muscleblind knockout model for myotonic dystrophy. Science 2003, 302:1978-1980.
34. Grzybowska E.A., Wilczynska A., Siedlecki J.A. Regulatory functions of 3?UTRs. Biochem. Biophys. Res. Commun. 2001, 288:291-295.
35. Davis B.M., McCurrach M.E., Taneja K.L., Singer R.H., Housman D.E. Expansion of a CUG trinucleotide repeat in the 3? untranslated region of myotonic dystrophy protein kinase transcripts results in nuclear retention of transcripts. Proc. Natl. Acad. Sci. USA 1997, 94:7388-7393.
36. Jiang H., Mankodi A., Swanson M.S., Moxley R.T., Thornton C.A. Myotonic dystrophy type 1 is associated with nuclear foci of mutant RNA, sequestration of muscleblind proteins and deregulated alternative splicing in neurons. Hum. Mol. Genet. 2004, 13:3079-3088.
37. Ho T.H., Savkur R.S., Poulos M.G., Mancini M.A., Swanson M.S., Cooper T.A. Colocalization of muscleblind with RNA foci is separable from mis-regulation of alternative splicing in myotonic dystrophy. J. Cell Sci. 2005, 118:2923-2933.
38. Harper P.S. Congenital myotonic dystrophy in Britain: I. Clinical aspects. Arch. Dis. Child. 1975, 50:505-513.
39. Sarnat H.B., Silbert S.W. Maturational arrest of fetal muscle in neonatal myotonic dystrophy: A pathologic study of four cases. Arch. Neurol. 1976, 33:466-474.
40. Furling D., Coiffier L., Mouly V., Barbet J.P., St Guily J.L., Taneja K., Gourdon G., Junien C., Butler-Browne G.S. Defective satellite cells in congenital myotonic dystrophy. Hum. Mol. Genet. 2001, 10:2079-2087.
41. Amack J.D., Mahadevan M.S. The myotonic dystrophy expanded CUG repeat tract is necessary but not sufficient to disrupt C2C12 myoblast differentiation. Hum. Mol. Genet. 2001, 10:1879-1887.
42. Brennan K.J., Hardeman E.C. Quantitative analysis of the human alpha-skeletal actin gene in transgenic mice. J. Biol. Chem. 1993, 268:719-725.
43. Wong L.J., Ashizawa T., Monckton D.G., Caskey C.T., Richards C.S. Somatic heterogeneity of the CTG repeat in myotonic dystrophy is age and size dependent. Am. J. Hum. Genet. 1995, 56:114-122.
44. Thornton C.A., Johnson K., Moxley R.T. Myotonic dystrophy patients have larger CTG expansions in skeletal muscle than in leukocytes. Ann. Neurol. 1994, 35:104-107.
45. Welle S., Bhatt K., Thornton C.A. Inventory of high-abundance mRNAs in skeletal muscle of normal men. Genome Res. 1999, 9:506-513.
46. Vassilopoulos D., Lumb E.M. Muscle nuclear changes in myotonic dystrophy. Eur. Neurol. 1980, 19:237-240.
47. Mankodi A., Takahashi M.P., Jiang H., Beck C.L., Bowers W.J., Moxley R.T., Cannon S.C., Thornton C.A. Expanded CUG repeats trigger aberrant splicing of CIC-1 chloride channel pre-mRNA and hyperexcitability of skeletal muscle in myotonic dystrophy. Mol. Cell. 2002, 10:35-44.
48. Furman R.E., Barchi R.L. The pathophysiology of myotonia produced by aromatic carboxylic acids. Ann. Neurol. 1978, 4:357-365.
49. Charlet B.N., Savkur R.S., Singh G., Phillips A.V., Grice E.A., Cooper T.A. Loss of the muscle-specific chloride channel in type 1 myotonic dystrophy due to misregulated alternative splicing. Mol. Cell. 2002, 10:45-53.
50. Seznec H., Agbulut O., Sergeant N., Savouret C., Ghestem A., Tabti N., Willer J.C., Ourth L., Duros C., Brisson E., et al. Mice transgenic for the human myotonic dystrophy region with expanded CTG repeats display muscular and brain abnormalities. Hum. Mol. Genet. 2001, 10:2717-2726.
51. Sergeant N., Sablonniere B., Schraen-Maschke S., Ghestem A., Maurage C.A., Wattez A., Vermersch P., Delacourte A. Dysregulation of human brain microtubule-associated tau mRNA maturation in myotonic dystrophy type 1. Hum. Mol. Genet. 2001, 10:2143-2155.
52. Gourdon G., Radvanyi F., Lia A.S., Duros C., Blanche M., Abitbol M., Junien C., Hofmann-Radvanyi H. Moderate intergenerational and somatic instability of a 55-CTG repeat in transgenic mice. Nat. Genet. 1997, 15:190-192.
53. Thornton C.A., Griggs R.C., Moxley R.T. Myotonic dystrophy with no trinucleotide repeat expansion. Ann. Neurol. 1994, 35:269-272.
54. Ricker K., Koch M.C., Lehmann-Horn F., Pongratz D., Otto M., Heine R., Moxley R.T. Proximal myotonic myopathy: A new dominant disorder with myotonia, muscle weakness, and cataracts. Neurology 1994, 44:1448-1452.
55. Margolis J.M., Ranum L.P.W., Day J.W. Clinical and genetic features of myotonic dystrophy type 2. Genetic Instabilities and Neurological Diseases 2006, Ch. 6, Elsevier, Burlington, MA. R.D. Wells, T. Ashizawa (Eds.).
56. Krahe R., Bachinski L.L. Myotonic dystrophy type 2: Clinical and genetic aspects. Genetic Instabilities, and Neurological Diseases 2006, Ch.7, Elsevier, Burlington, MA. R.D. Wells, T. Ashizawa (Eds.).
57. Hamshere M.G., Newman E.E., Alwazzan M., Athwal B.S., Brook J.D. Transcriptional abnormality in myotonic dystrophy affects DMPK but not neighboring genes. Proc. Natl. Acad. Sci. USA 1997, 94:7394-7399.
58. Taneja K.L. Localization of trinucleotide repeat sequences in myotonic dystrophy cells using a single fluorochrome-labeled PNA probe. Biotechniques 1998, 24:472-476.
59. Mankodi A., Teng-Umnuay P., Krym M., Henderson D., Swanson M., Thornton C.A. Ribonuclear inclusions in skeletal muscle in myotonic dystrophy types 1 and 2. Ann. Neurol. 2003, 54:760-768.
60. DeCerbo J., Carmichael G.G. Retenton and repression: Fates of hyperedited RNAs in the nucleus. Curr. Opin. Cell Biol. 2005, 17:302-308.
61. Kumar M., Carmichael G.G. Nuclear antisense RNA induces extensive adenosine modifications and nuclear retention of target transcripts. Proc. Natl. Acad. Sci. USA 1997, 94:3542-3547.
62. Houseley J.M., Wang Z., Brock G.J., Soloway J., Artero R., Perez-Alonso M., O'Dell K.M., Monckton D.G. Myotonic dystrophy associated expanded CUG repeat museleblind positive ribonuclear foci are not toxic to Drosophila. Hum. Mol. Genet. 2005, 14:873-883.
63. Peng R., Dye B.T., Perez I., Barnard D.C., Thompson A.B., Patton J.G. PSF and p54nrb bind a conserved stem in U5 snRNA. RNA 2002, 8:1334-1347.
64. Shav-Tal Y., Zipori D. PSF and p54(nrb)/NonO: Multi-functional nuclear proteins. FEBS Lett. 2002, 531:109-114.
65. Dansithong W., Paul S., Comai L., Reddy S. MBNL1 is the primary determinant of focus formation and aberrant insulin receptor splicing in DM1. J. Biol. Chem. 2005, 280:5773-5780.
66. Mankodi A., Urbinati C.R., Yuan Q.P., Moxley R.T., Sansone V., Krym M., Henderson D., Schalling M., Swanson M.S., Thornton C.A. Muscleblind localizes to nuclear foci of aberrant RNA in myotonic dystrophy types 1 and 2. Hum. Mol. Genet. 2001, 10:2165-2170.
67. Arrasate M., Mitra S., Schweitzer E.S., Segal M.R., Finkbeiner S. Inclusion body formation reduces levels of mutant huntingtin and the risk of neuronal death. Nature 2004, 431:805-810.
68. Denis M.M., Tolley N.D., Bunting M., Schwertz H., Jiang H., Lindemann S., Yost C.C., Rubner F.J., Albertine K.H., Swoboda K.J., et al. Escaping the nuclear confines Signal-dependent pre-mRNA splicing in anucleate platelets. Cell 2005, 122:379-391.
69. Johnson J.M., Castle J., Garrett-Engele P., Kan Z., Loerch P.M., Armour C.D., Santos R., Schadt E.E., Stoughton R., Shoemaker D.D. Genome-wide survey of human alternative pre-mRNA splicing with exon junction microarrays. Science 2003, 302:2141-2144.
70. Modrek B., Resch A., Grasso C., Lee C. Genomewide detection of alternative splicing in expressed sequences of human genes. Nucleic Acids Res. 2001, 29:2850-2859.
71. Lewis B.P., Green R.E., Brenner S.E. Evidence for the widespread coupling of alternative splicing and nonsense-mediated mRNA decay in humans. Proc. Natl. Acad. Sci. USA 2003, 100:189-192.
72. Black D.L. Mechanisms of alternative pre-messenger RNA splicing. Annu. Rev. Biochem. 2003, 72:291-336.
73. Faustino N.A., Cooper T.A. Pre-mRNA splicing and human disease. Genes Dev. 2003, 17:419-437.
74. n triplet repeat RNA-binding protein and its expression in myotonic dystrophy. Nucleic Acids Res. 1996, 24:4407-4414.
75. Cartegni L., Chew S.L., Krainer A.R. Listening to silence and understanding nonsense: Exonic mutations that affect splicing. Nat. Rev. Genet. 2002, 3:285-298.
76. 2+ binding associated with troponin T isoform switching in developing rabbit heart. Circ. Res. 1990, 66:1204-1216.
77. Phillips M.F., Harper P.S. Cardiac disease in myotonic dystrophy. Cardiovasc. Res. 1997, 33:13-22.
78. Vinereanu D., Bajaj B.P., Fenton-May J., Rogers M.T., Madler C.F., Fraser A.G. Subclinical cardiac involvement in myotonic dystrophy manifesting as decreased myocardial Doppler velocities. Neuromuscul. Disord. 2004, 14:188-194.
79. Savkur R.S., Philips A.V., Cooper T.A. Aberrant regulation of insulin receptor alternative splicing is associated with insulin resistance in myotonic dystrophy. Nat. Genet. 2001, 29:40-47.
80. Savkur R.S., Philips A.V., Cooper T.A., Dalton J.C., Moseley M.L., Ranum L.P., Day J.W. Insulin receptor splicing alteration in myotonic dystrophy type 2. Am. J. Hum. Genet. 2004, 74:1309-1313.
81. D'Souza I., Schellenberg G.D. Regulation of tau isoform expression and dementia. Biochim. Biophys. Acta 2005, 1739:104-115.
82. Gao L., Tucker K.L., Andreadis A. Transcriptional regulation of the mouse microtubule-associated protein tau. Biochim. Biophys. Acta 2005, 1681:175-181.
83. Vermersch P., Sergeant N., Ruchoux M.M., Hofmann-Radvanyi H., Wattez A., Petit H., Dwailly P., Delacourte A. Specific au variants in the brains of patients with myotonic dystrophy. Neurology 1996, 47:711-717.
84. Kiuchi A., Otsuka N., Namba Y., Nakano I., Tomonaga M. Presenile appearance of abundant Alzheimer's neurofibrillary tangles without senile plaques in the brain in myotonic dystrophy. Acta Neuropathol. (Berlin) 1991, 82:1-5.
85. Modoni A., Silvestri G., Pomponi M.G., Mangiola F., Tonali P.A., Marra C. Characterization of the pattern of cognitive impairment in myotonic dystrophy type 1. Arch. Neurol. 2004, 61:1943-1947.
86. 2+-ATPase in myotonic dystrophy type 1. Hum. Mol. Genet. 2005, 14:2189-2200.
87. Futatsugi A., Kuwajima G., Mikoshiba K. Tissue-specific and developmentally regulated alternative splicing in mouse skeletal muscle ryanodine receptor mRNA. Biochem. J. 1995, 305(Pt. 2):373-378.
88. Buj-Bello A., Furling D., Tronchere H., Laporte J., Lerouge T., Butler-Browne G.S., Mandel J.L. Muscle-specific alternative splicing of myotubularin-related 1 gene is impaired in DM1 muscle cells. Hum. Mol. Genet. 2002, 11:2297-2307.
89. Ho T.H., Bundman D., Armstrong D.L., Cooper T.A. Transgenic mice expressing CUG-BP1 reproduce splicing mis-regulation observed in myotonic dystrophy. Hum. Mol. Genet. 2005, 14:1539-1547.
90. Copley L.M., Zhao W.D., Kopacz K., Herman G.E., Kioschis P., Poustka A., Taudien S., Platzer M. Exclusion of mutations in the MTMR1 gene as a frequent cause of X-linked myotubular myopathy. Am. J. Med. Genet. 2002, 107:256-258.
91. Sandbrink R., Hartmann T., Masters C.L., Beyreuther K. Genes contributing to Alzheimer's disease. Mol. Psychiatry 1996, 1:27-40.
92. Johnson S.A., Pasinetti G.M., May P.C., Ponte P.A., Cordell B., Finch C.E. Selective reduction of mRNA for the beta-amyloid precursor protein that lacks a Kunitz-type protease inhibitor motif in cortex from Alzheimer brains. Exp. Neurol. 1988, 102:264-268.
93. Cull-Candy S.G., Leszkiewicz D.N. Role of distinct NMDA receptor subtypes at central synapses. Sci STKE 2004, 2004:re16.
94. Lu X., Timchenko N.A., Timchenko L.T. Cardiac elav-type RNA-binding protein (ETR-3) binds to RNA CUG repeats expanded in myotonic dystrophy. Hum. Mol. Genet. 1999, 8:53-60.
95. Tian B., White R.J., Xia T., Welle S., Turner D.H., Mathews M.B., Thornton C.A. Expanded CUG repeat RNAs form hairpins that activate the double-stranded RNA-dependent protein kinase PKR. RNA 2000, 6:79-87.
96. Kim D.H., Langlois M.A., Lee K.B., Riggs A.D., Puymirat J., Rossi J.J. HnRNP H inhibits nuclear export of mRNA containing expanded CUG repeats and a distal branch point sequence. Nucleic Acids Res. 2005, 33:3866-3874.
97. Timchenko N.A., Welm A.L., Lu X., Timchenko L.T. CUG repeat binding protein (CUGBP1) interacts with the 5? region of C/EBP beta mRNA and regulates translation of C/EBPbeta isoforms. Nucleic Acids Res. 1999, 27:4517-4525.
98. Anant S., Henderson J.O., Mukhopadhyay D., Navaratnam N., Kennedy S., Min J., Davidson N.O. Novel role for RNA-binding protein CUGBP2 in mammalian RNA editing. CUGBP2 modulates C to U editing of apolipoprotein B mRNA by interacting with apobec-1 and ACF, the apobec-1 complementation factor. J. Biol. Chem. 2001, 276:47338-47351.
99. Paillard L., Omilli F., Legagneux V., Bassez T., Maniey D., Osborne H.B. EDEN and EDEN-BP, a cis element and an associated factor that mediate sequence-specific mRNA deadenylation in Xenopus embryos. EMBO J. 1998, 17:278-287.
100. Ladd A.N., Charlet N., Cooper T.A. The CELF family of RNA binding proteins is implicated in cell-specific and developmentally regulated alternative splicing. Mol. Cell. Biol. 2001, 21:1285-1296.
101. Mukhopadhyay D., Houchen C.W., Kennedy S., Dieckgraefe B.K., Anant S. Coupled mRNA stabilization and translational silencing of cyclooxygenase-2 by a novel RNA binding protein, CUGBP2. Mol. Cell. 2003, 11:113-126.
102. Ho T.H., Charlet B.N., Poulos M.G., Singh G., Swanson M.S., Cooper T.A. Muscleblind proteins regulate alternative splicing. EMBO J. 2004, 23:3103-3112.
103. Arhin G.K., Boots M., Bagga P.S., Milcarek C., Wilusz J. Downstream sequence elements with different affinities for the hnRNP H/H? protein influence the processing efficiency of mammalian polyadenylation signals. Nucleic Acids Res. 2002, 30:1842-1850.
104. Chen C.D., Kobayashi R., Helfman D.M. Binding of hnRNP H to an exonic splicing silencer is involved in the regulation of alternative splicing of the rat beta-tropomyosin gene. Genes Dev. 1999, 13:593-606.
105. Chou M.Y., Rooke N., Turck C.W., Black D.L. hnRNP H is a component of a splicing enhancer complex that activates a c-src alternative exon in neuronal cells. Mol. Cell. Biol. 1999, 19:69-77.
106. Fardaei M., Rogers M.T., Thorpe H.M., Larkin K., Hamshere M.G., Harper P.S., Brook J.D. Three proteins, MBNL, MBLL and MBXL, co-localize in vivo with nuclear foci of expanded-repeat transcripts in DM1 and DM2 cells. Hum. Mol. Genet. 2002, 11:805-814.
107. Ladd A.N., Stenberg M.G., Swanson M.S., Cooper T.A. Dynamic balance between activation and repression regulates pre-mRNA alternative splicing during heart development. Dev. Dyn. 2005, 233:783-793.
108. Han J., Cooper T.A. Identification of CELF splicing activation and repression domains in vivo. Nucleic Acids Res. 2005, 33:2769-2780.
109. Faustino N.A., Cooper T.A. Identification of putative new splicing targets for ETR-3 using sequences identified by systematic evolution of ligands by exponential enrichment. Mol. Cell. Biol. 2005, 25:879-887.
110. Zhang W., Liu H., Han K., Grabowski P.J. Region-specific alternative splicing in the nervous system: Implications for regulation by the RNA-binding protein NAPOR. RNA 2002, 8:671-685.
111. Michalowski S., Miller J.W., Urbinati C.R., Paliouras M., Swanson M.S., Griffith J. Visualization of double-stranded RNAs from the myotonic dystrophy protein kinase gene and interactions with CUG-binding protein. Nucleic Acids Res. 1999, 27:3534-3542.
112. Sobczak K., de Mezer M., Michlewski G., Krol J., Krzyzosiak W.J. RNA structure of trinucleotide repeats associated with human neurological diseases. Nucleic Acids Res. 2003, 31:5469-5482.
113. Fardaei M., Larkin K., Brook J.D., Hamshere M.G. In vivo co-localisation of MBNL protein with DMPK expanded-repeat transcripts. Nucleic Acids Res. 2001, 29:2766-2771.
114. Artero R., Prokop A., Paricio N., Begemann G., Pueyo I., Mlodzik M., Perez-Alonso M., Baylies M.K. The muscleblind gene participates in the organization of Z-bands and epidermal attachments of Drosophila muscles and is regulated by Dmef2. Dev. Biol. 1998, 195:131-143.
115. Begemann G., Paricio N., Artero R., Kiss I., Perez-Alonso M., Mlodzik M. muscleblind, a gene required for photoreceptor differentiation in Drosophila, encodes novel nuclear Cys3His-type zinc-finger-containing proteins. Development 1997, 124:4321-4331.
116. Kino Y., Mori D., Oma Y., Takeshita Y., Sasagawa N., Ishiura S. Muscleblind protein, MBNL1/EXP, binds specifically to CHHG repeats. Hum. Mol. Genet. 2004, 13:495-507.
117. Iakova P., Wang G.L., Timchenko L., Michalak M., Pereira-Smith O.M., Smith J.R., Timchenko N.A. Competition of CUGBP1 and calreticulin for the regulation of p21 translation determines cell fate. EMBO J. 2004, 23:406-417.
118. Shimizu K., Chen W., Ashique A.M., Moroi R., Li Y.P. Molecular cloning, developmental expression, promoter analysis and functional characterization of the mouse CNBP gene. Gene 2003, 307:51-62.